Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$786M |
| 2 |
Apple
AAPL
|
+$564M |
| 3 |
Amazon
AMZN
|
+$486M |
| 4 |
Meta Platforms (Facebook)
META
|
+$331M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$327M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sherwin-Williams
SHW
|
+$1.88B |
| 2 |
Alibaba
BABA
|
+$1.21B |
| 3 |
Home Depot
HD
|
+$320M |
| 4 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$274M |
| 5 |
FLIR
FLIR Systems, Inc. (DE) Common Stock
FLIR
|
+$135M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.98% |
| 2 | Financials | 13.87% |
| 3 | Healthcare | 13.39% |
| 4 | Consumer Discretionary | 11.81% |
| 5 | Communication Services | 10.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3151
Disc Medicine
IRON
$2.96B
| $2.94M | ﹤0.01% |
15,140
+5,788
| +62% | +$1.9M |
|
3152
Lifetime Brands
LCUT
$191M
| $2.94M | ﹤0.01% |
196,162
+22,554
| +13% | +$346K |
|
3153
PubMatic
PUBM
$585M
| $2.93M | ﹤0.01% |
74,905
+16,778
| +29% | +$698K |
|
3154
Oramed Pharmaceuticals
ORMP
$167M
| $2.91M | ﹤0.01% |
217,708
+200,751
| +1,184% | +$2.3M |
|
|
CRON
3155
Cronos Group
CRON
$1.06B
| $2.88M | ﹤0.01% |
335,126
+9,128
| +3% | +$75.5K |
|
|
GORV
3156
DELISTED
Lazydays
GORV
| $2.87M | ﹤0.01% |
4,353
+2,436
| +127% | +$1.66M |
|
|
MBII
3157
DELISTED
Marrone Bio Innovations, Inc.
MBII
| $2.85M | ﹤0.01% |
1,719,066
+299,945
| +21% | +$501K |
|
3158
YPF
YPF
$206B
| $2.85M | ﹤0.01% |
614,203
+123,891
| +25% | +$557K |
|
|
TLIS
3159
DELISTED
Talis Biomedical Corporation Common Stock
TLIS
| $2.85M | ﹤0.01% |
17,203
+1,735
| +11% | +$295K |
|
3160
Methanex
MEOH
$4.3B
| $2.84M | ﹤0.01% |
85,903
+2,140
| +3% | +$78.7K |
|
3161
Hurco Companies Inc
HURC
$135M
| $2.84M | ﹤0.01% |
81,074
-42,383
| -34% | -$1.47M |
|
3162
iRadimed
IRMD
$1.16B
| $2.84M | ﹤0.01% |
96,483
+8,237
| +9% | +$227K |
|
3163
Lyell Immunopharma
LYEL
$317M
| $2.83M | ﹤0.01% |
+8,721
| New | +$2.86M |
|
3164
HBT Financial
HBT
$1.3B
| $2.83M | ﹤0.01% |
162,614
+2,061
| +1% | +$36.6K |
|
3165
Equinor
EQNR
$97.7B
| $2.83M | ﹤0.01% |
133,434
+1,461
| +1% | +$30.8K |
|
3166
Bioventus
BVS
$892M
| $2.82M | ﹤0.01% |
160,173
+25,172
| +19% | +$406K |
|
|
VZIO
3167
DELISTED
VIZIO Holding Corp.
VZIO
| $2.82M | ﹤0.01% |
+104,269
| New | +$2.45M |
|
3168
NI Holdings
NODK
$310M
| $2.81M | ﹤0.01% |
147,839
+8,204
| +6% | +$158K |
|
3169
HDFC Bank
HDB
$123B
| $2.81M | ﹤0.01% |
76,836
+948
| +1% | +$34.7K |
|
3170
Safe Bulkers
SB
$795M
| $2.8M | ﹤0.01% |
698,678
+267,707
| +62% | +$938K |
|
|
CYBE
3171
DELISTED
Cyberoptics Corp
CYBE
| $2.79M | ﹤0.01% |
68,076
-49,880
| -42% | -$1.55M |
|
|
PLXP
3172
DELISTED
PLx Pharma Inc. Common Stock
PLXP
| $2.77M | ﹤0.01% |
200,841
+38,345
| +24% | +$454K |
|
|
CAJ
3173
DELISTED
Canon, Inc.
CAJ
| $2.73M | ﹤0.01% |
120,799
+8,341
| +7% | +$197K |
|
3174
Oil-Dri
ODC
$1.44B
| $2.71M | ﹤0.01% |
158,528
+12,002
| +8% | +$213K |
|
|
GRFS
3175
Grifois
GRFS
$5.36B
| $2.69M | ﹤0.01% |
155,363
-6,411
| -4% | -$115K |
|
Similar funds
Geode Capital Management's Q2 2021 Portfolio in Review
As of Q2 2021, Geode Capital Management held 4,790 positions worth $726B, up 11% from $654B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Geode Capital Management's Q2 2021 filing shows 331 new, 3,384 increased, 720 reduced and 74 closed positions. Its largest new stake was Organon & Co: 5,070,121 shares worth $153M. The largest sale was Sherwin-Williams, an estimated $1.88B.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.
- Geode Capital Management's largest Q2 2021 buy was Organon & Co: 5,070,121 shares worth $153M.
- Geode Capital Management added most to Microsoft in Q2 2021, an estimated $786M increase.
- Geode Capital Management's biggest Q2 2021 reduction was Sherwin-Williams, cutting an estimated $1.88B.
- Geode Capital Management fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $274M.
- Geode Capital Management's ten largest holdings make up 22% of its $726B portfolio in Q2 2021.
- Geode Capital Management opened 331 new positions and closed 74 in Q2 2021.
- Geode Capital Management's portfolio value rose 11% quarter-over-quarter to $726B.
Based on Geode Capital Management's 13F filing for Q2 2021, filed 13 Aug 2021.